Robert Hof
Directeur des opérations chez Syncom BV
Profil
Robert Hof currently works at Symeres BV, as Managing Director from 2020 and Syncom BV, as Chief Operating Officer.
Postes actifs de Robert Hof
| Sociétés | Poste | Début |
|---|---|---|
Syncom BV
 Syncom BV Miscellaneous Commercial ServicesCommercial Services Syncom BV is a contract research organization that specializes in all aspects of organic synthesis. Syncom focuses on synthetic chemistry support for mainly medicinal chemistry and chemical development groups. Areas of expertise include asymmetric synthesis, vitamin D and steroid syntheses and heterocyclic chemistry. Dutch resolution is a unique technology used for resolution of racemates by means of diastereomeric salt formation. Chirality in general is specialty of Syncom. About 90% of te current work is done for the pharmaceutical industry and the other 10% for companies interested in materials including organic semiconductors and film components. Syncom is privately owned and was incorporated in 1988. | Directeur des opérations | 06/05/2011 |
Symeres BV
 Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Corporate Officer/Principal | 01/03/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Syncom BV
Syncom BV Miscellaneous Commercial ServicesCommercial Services Syncom BV is a contract research organization that specializes in all aspects of organic synthesis. Syncom focuses on synthetic chemistry support for mainly medicinal chemistry and chemical development groups. Areas of expertise include asymmetric synthesis, vitamin D and steroid syntheses and heterocyclic chemistry. Dutch resolution is a unique technology used for resolution of racemates by means of diastereomeric salt formation. Chirality in general is specialty of Syncom. About 90% of te current work is done for the pharmaceutical industry and the other 10% for companies interested in materials including organic semiconductors and film components. Syncom is privately owned and was incorporated in 1988. | Commercial Services |
Symeres BV
Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Health Technology |
